Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 7006049649

Activities

Collapse all

Employment (4)

Queen Mary University of London: London, London, GB

2009 to present | Professor of Neuropharmacology (Blizard Institute)
Employment
Source: Self-asserted source
Gareth Sanger

GlaxoSmithKline Research and Development: Harlow, Essex, GB

2000 to 2009 | Senior Team Leader and Manager (Gastrointestinal and ImmunoInflammation)
Employment
Source: Self-asserted source
Gareth Sanger

SmithKline Beecham Pharma: Harlow, GB

1980 to 2000 | Director (Beecham), Senior Team Leader (SmithKline Beecham) (Gastrointestinal and Neuroscience)
Employment
Source: Self-asserted source
Gareth Sanger

Kings College London: London, GB

1977 to 1980 | Research Fellow (Hospital Medical School)
Employment
Source: Self-asserted source
Gareth Sanger

Education and qualifications (3)

University of Manchester: Manchester, Manchester, GB

1998 to 1998 | DSc (Biological Sciences)
Education
Source: Self-asserted source
Gareth Sanger

University of Manchester: Manchester, Manchester, GB

1974 to 1977 | PhD (Physiology)
Education
Source: Self-asserted source
Gareth Sanger

Newcastle University: Newcastle upon Tyne, Newcastle upon Tyne, GB

1971 to 1974 | BSc Honours Upper Second (Physiology)
Education
Source: Self-asserted source
Gareth Sanger

Funding (1)

Neuromuscular drug targets

2015-01 to 2018-07 | Grant
Takeda Pharmaceutical Company (-, -, US)
URL: http://-
GRANT_NUMBER: -
Source: Self-asserted source
Gareth Sanger
grade
Preferred source (of 5)‎

Peer review (4 reviews for 3 publications/grants)

Review activity for Molecular metabolism. (2)
Review activity for Nature communications (1)
Review activity for Naunyn-Schmiedeberg's archives of pharmacology (1)
How many people are using ORCID?